-
. Research from UK DRI at UCL covers the journey from the patient to the laboratory and back to the patient with improved diagnosis, biomarkers and candidate therapies put to the test. The Hong Laboratory
-
dementia. The Bourdenx Lab at the UK DRI, led by Dr Mathieu Bourdenx, focuses on how age-related loss of cellular fitness in the brain drives neurodegeneration. Using cutting-edge spatial biology and single
-
single-cell and spatial transcriptomics to uncover the mechanisms driving cell state rewiring and therapeutic resistance in cancer. This project is funded by CRUK Cancer Grand Challenges REWIRE-CAN
-
the University of Oslo, industry partners and University College London (UCL). The successful candidate will work with and further develop the electricity system model highRES to analyse the role of batteries in
-
across the University of Oslo, industry partners and University College London (UCL). The successful candidate will work with and further develop the electricity system model highRES to analyse the role